CLINICAL_TRIALS
trial_result
· 2022-11-02
Clinical Trial Update: Clinical Efficacy of the Drug Ster® Compared With Predfort® in Control of Postoperative Inflammation in Cataract Surgery [Phase 3]
Summary
Phase 3 trial assessing the efficacy of Ster® versus Predfort® in controlling postoperative inflammation after cataract surgery.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Azidus Brasil | Conditions: Inflammation, Cataract Surgery | Phase 3 | Status: COMPLETED